Novo CEO pressed by Senate to chop price ranges of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the business would consider new talks with insurers in regards to the listing costs of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://busch-peach-calories61504.pointblog.net/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-72614152